EXIDE INDUSTRIES LTD (EXIDEIND): Financials & Fundamentals History

Share price

Closing priceAdjusted for splits and bonus issues.

3M1Y3YAll

₹385.05 latest close · −7.6% over the last 90 sessions

₹385.05 month-end · +2.7% over 12 months

₹385.05 month-end · +35.2% over 3 years

₹385.05 month-end · +69.7% since Jan '19

52-week range ₹287.00 to ₹496.40 · 1-year volatility 31.8%

Was the rally earned?

1 year3 years5 years

+3%share price, 1 yearRoughly flat

The share price was roughly flat over 1 year (+3%).
The share count barely moved.

Net profit growth+9 ptsNet profit rose about 9%, which lifts the price.

P/E change-7 ptsThe P/E fell from 37.6x to 35.2x, which lowers the price.

Share count change+1 ptsShare count was little changed. More shares would count against the price.

+35%share price, 3 yearsEarnings and multiple

Both mattered.

Per-share earnings added 14 points and the multiple added 21 points (P/E 29.4x to 35.2x).
The share count barely moved.

Net profit growth+14 ptsNet profit rose about 13%, which lifts the price.

P/E change+21 ptsThe P/E rose from 29.4x to 35.2x, which lifts the price.

Share count change0 ptsShare count was little changed. More shares would count against the price.

+137%share price, 5 yearsMultiple-driven

Partly.

Most of the rise came from investors paying a higher multiple (P/E 17.1x to 35.2x); per-share earnings added 22 points.
The share count barely moved.

Net profit growth+23 ptsNet profit rose about 16%, which lifts the price.

P/E change+115 ptsThe P/E rose from 17.1x to 35.2x, which lifts the price.

Share count change-1 ptsShare count was little changed. More shares would count against the price.

What do "pts" mean?

"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.

Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.

Net profit is trailing twelve months as reported with a 60-day lag.

Compare this with SAMVARDHANA MOTHERSON INT

How rough has the ride been?

Maximum drawdown-52.6%recovered 2023-08

1-year volatility31.8%annualised

Beta vs sector index1.013-year daily, correlation 0.62

Volume spikes3last 90 sessions, 5x the 50-day median

Drawdown from peak

Largest drawdowns

-52.6% (2019-01 peak to 2020-03 low, recovered 2023-08)

-50.3% (2024-06 peak to 2026-03 low, not yet recovered)

Most recent volume spikes

2026-11-04: 5.8x the 50-day median, price +6.4% that day

2026-07-30: 10.8x the 50-day median, price +3.9% that day

2026-07-17: 5.5x the 50-day median, price +3.3% that day

Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).

Is it expensive against its own past and its peers?

35.2xP/E todayWithin its usual range

Against its own history71st percentile

CheapestMedian 22.2xDearest

Usual range 3.7x to 43.3x since 2019-01.

Against Producer Manufacturing35.2x vs 29.6x

This company

35.2x

Sector median

29.6x

19% above the Producer Manufacturing median.

P/EP/BP/S

P/E (this company)10th to 90th percentile of its own historyIts medianProducer Manufacturing median

The chart loads when you open this tab.

P/B (this company)10th to 90th percentile of its own historyIts medianProducer Manufacturing median

The chart loads when you open this tab.

P/S (this company)10th to 90th percentile of its own historyIts medianProducer Manufacturing median

How to read this

Shaded band: 10th to 90th percentile of the company's own P/E history; dotted line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).

Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.

All terms explained in the glossary →

How Producer Manufacturing is valued

Where does it rank among Producer Manufacturing peers?

Each cell is the company's percentile rank among its Producer Manufacturing peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

Where it ranks today

ROCE24thflat vs a year ago
Op. margin45thflat vs a year ago
Revenue growth31st▼ 3 pts vs a year ago
EPS growth49th▲ 11 pts vs a year ago
Debt/equity ↓66th▲ 6 pts vs a year ago
Cash cycle ↓80th▲ 13 pts vs a year ago
P/E ↓39th▼ 3 pts vs a year ago
12M momentum58th▲ 10 pts vs a year ago

Rank history

ROCE

Op. margin

Revenue growth

EPS growth

Debt/equity ↓

Cash cycle ↓

P/E ↓

12M momentum

Dec '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '26Nov '26

Lower rank Higher rank Not enough data

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Producer Manufacturing sector page Watch it move against Producer Manufacturing in the Observatory

What is the price implying?

~15%annual earnings growth implied by the priceAbove delivered growth

At normalised P/E (five-year average earnings) of 21.3x, a holder earning 12%/yr needs earnings to grow about 14.7%/yr for 10 years, then trade at 15x.

Delivered1.2%/yrEPS, last 10 fiscal years · 3-yr avg to 3-yr avg

Gap+13.5 ptsimplied minus delivered

Rank249thmost demanding of 856

Over time

Implied growth by month (solid) and delivered growth (dashed).

Change the assumptions

Exit P/E / return	11%	12%	13%
12x	16.1%	17.1%	18.2%
15x	13.7%	14.7%	15.7%
20x	10.6%	11.6%	12.6%

Drag a slider to test other assumptions

Required return 12.0% Years 10 Exit P/E 15x Implied: 14.7%/yr

Looking back

Jan 2020Price implied 13%/yr; EPS has since grown 0%/yr (7.0 yrs)
Jan 2021Price implied 14%/yr; EPS has since grown 2%/yr (6.0 yrs)
Jan 2022Price implied 13%/yr; EPS has since grown 1%/yr (5.0 yrs)

Past comparisons cover only companies listed today (survivorship bias) and say nothing about future outcomes.

“Implied growth” is what the current price would require under our stated assumptions, not what we expect. How this is calculated and the market-wide lists.

What prices imply across Producer Manufacturing The market-wide Expectations lists

Key figures

Share Priceclose 9 Nov: ₹385.05
P/E: 35.2x
ROCE: 9.0%
Market Cap: ₹32681 cr
Revenue (TTM): ₹18829 cr
P/S: 1.7x
P/B: 2.4x
ROE: 6.7%
Operating Margin: 11.0%
Debt / Equity: 0.1x
Promoter Holding: 46.0%
12M Momentum: 2.7%

52-week range

₹287.00₹496.40

47% of the way from its 52-week low to its high

Price risk

1Y volatility

31.8%

Beta vs sector

1-year daily

0.90

Balance sheet & cash

Interest cover

operating profit ÷ interest

13.0x

Cash from profit, 3Y

operating cash flow ÷ net profit

2.05x

Share count, 1Y

unchanged

Are profits backed by cash?

5 of 7checks within range2 beyond a threshold

Other income reliance7%Within range

Other income as a share of pre-tax profit (trailing twelve months): 6.7%. Bands: below 15%, 15% to 35%, above 35%.

Tax rate31%Within range

Median quarterly effective tax rate over about 2.5 years: 31.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.

Cash conversion2.05xWithin range

Operating cash flow divided by net profit over the last three fiscal years: 2.05x (cash from operations ₹5,219 cr, net profit ₹2,543 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.

Free cash flow1 of 5 yrsBeyond threshold

Fiscal years with positive free cash flow in the last 5: 1. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history+2 daysWithin range

Debtor days are above the median of the previous three fiscal years by 2 days (32 vs 30). Bands: under 15 days, 15 to 45, over 45.

Capital work in progress105% of fixed assetsBeyond threshold

Capital work-in-progress is 105% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days+23 days / 2 yrsWithin range

Days payable changed by +23 over two years. Bands: rise of up to 30 days; more than 30 days.

Tap a check to see how it is measured

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

Who has been buying and selling?

Over 2 years, FIIs trimmed 2.3 pts.
The number of shareholders rose from 8.6 lakh to 11.7 lakh (+35%) between Dec 2023 and Jun 2026.

Holdings, Jun '26

How each group changed

GroupDec '23Jun '26Change

Promoters46.0%46.0%0.0 pts

FIIs12.9%10.6%-2.3 pts

DIIs19.2%19.3%+0.1 pts

Public and others21.8%24.1%+2.3 pts

Number of shareholders

11.7 lakhshareholders+35% since Dec '23

Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.

This quarter's smart-money board

What happened next to similar setups

−7.8%typical 12-month return vs the marketNot meaningfully different from the base rate

We found 50 past situations where a non-financial company looked like EXIDE INDUSTRIES LTD today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
Over the following 12 months the middle half of them returned −24% to +17% vs the market, against −8% for all non-financial companies in the same months.
The gap against the base rate (+0.3%, 80% range −7.8% to +7.7%) is within what chance and overlapping periods produce.

Where the 50 outcomes landed

Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 2 beyond the range shown, drawn at the edge

Similar setups' median

−7.8%

All companies' median

−8.1%

Beat the market

44% vs 41%

50 past situations · 50 companies · 30 months · 2020–2025

The closest matches

Company	When	P/E	ROCE	12M mom.	Drawdown	Next 12 months
APLLTD Health Technology	May 2024	53x	7%	+69%	−15%	+5%
IPCALAB Health Technology	May 2024	62x	11%	+64%	−15%	+18%
AUROPHARMA Health Technology	Aug 2023	25x	9%	+52%	−6%	+28%
DALBHARAT Non-Energy Minerals	Aug 2023	38x	8%	+36%	−8%	−38%
GRAPHITE Process Industries	Oct 2023	46x	7%	+32%	−10%	−19%

Show the other 3 matches

Company	When	P/E	ROCE	12M mom.	Drawdown	Next 12 months
CROMPTON Producer Manufacturing	Apr 2025	41x	16%	+6%	−29%	−24%
VTL Process Industries	Jan 2022	33x	8%	+130%	−15%	−37%
ENDURANCE Producer Manufacturing	Apr 2024	58x	14%	+47%	−8%	−7%

How reliable is this?

Matched on P/E, P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: P/E, 12-month momentum and revenue growth. One match per company and at most 7 from any one month.

Independent periods: the matches fall in 5 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.

How this is built

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to EXIDE INDUSTRIES LTD. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Methodology

How historical analogs are built

Data as of 2026-11-09. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

Feature	Weight	Non-financial	Financial
P/E	1	yes	yes
P/S	1	yes	—
P/B	1	—	yes
ROCE	1	yes	—
operating margin	1	yes	—
ROE	1	—	yes
debt/equity	0.75	yes	—
interest cover	0.5	yes	—
revenue growth	0.75	yes	yes
12-month momentum	1	yes	yes
drawdown from 12-month high	0.75	yes	yes
size	0.75	yes	yes
volatility	0.5	yes	yes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
Pools: non-financial: 98,395 company-months from 2019 companies; financial: 5,659 company-months from 108 companies. 2349 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

What else looks like this?

Companies with the most similar financial profile today, regardless of industry.

CYIENTCYIENT

Technology Services

70%similar

revenue growthP/E

DR REDDYS LABORATORIESDRREDDY

Health Technology

70%similar

operating marginP/E

TATA CONSUMER PRODUCTSTATACONSUM

Consumer Non-Durables

67%similar

ROCErevenue

WHIRLPOOL OF INDIAWHIRLPOOL

Consumer Durables

67%similar

revenue growthEPS growth

RELIANCE INDUSTRIESRELIANCE

Energy Minerals

64%similar

EPS growthrevenue growth

TITAGARH RAIL SYSTEMSTITAGARH

Producer Manufacturing

64%similar

operating marginrevenue growth

AMARA RAJA ENERGY & MOBILITYARE&M

Producer Manufacturing

63%similar

volatilityrevenue

SUNDRAM FASTENERSSUNDRMFAST

Producer Manufacturing

62%similar

promoter holdingmarket cap

Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.

What changed?

30 events since Jun '21

2026
NovPriceVolume reached 5.8x its 50-day median on 2026-11-04; price +6.4% that day.
JulValuationP/E crossed above the 90th percentile of its own history to date (44.8x).
JulPriceVolume reached 10.8x its 50-day median on 2026-07-30; price +3.9% that day.
MayPriceVolume reached 12.3x its 50-day median on 2026-05-27; price +7.6% that day.
MarResultsYear-on-year EPS growth turned positive.
MarPriceFell 50% from the Jun 2024 peak to the Mar 2026 low.
FebPriceVolume reached 6.9x its 50-day median on 2026-02-04; price +4.1% that day.
2025
AugPriceVolume reached 11.8x its 50-day median on 2025-08-19; price +4.4% that day.

Show 22 earlier events

2025
MarResultsYear-on-year EPS growth turned negative.
2024
SepPriceVolume reached 5.0x its 50-day median on 2024-09-27; price +5.4% that day.
JunResultsYear-on-year EPS growth turned positive.
JunPeer rankSlipped to the bottom quartile of Producer Manufacturing on ROCE (from the 3rd quartile).
AprPriceVolume reached 35.4x its 50-day median on 2024-04-08; price +17.2% that day.
2023
AugPriceRegained the 2019-01 peak, 41 months after the low.
AugPriceVolume reached 5.4x its 50-day median on 2023-08-01; price +5.4% that day.
JunResultsYear-on-year EPS growth turned negative.
JunValuationP/E crossed above the 90th percentile of its own history to date (24.5x).
JunPeer rankSlipped to the bottom quartile of Producer Manufacturing on EPS growth (from the top quartile).
MayPriceVolume reached 15.1x its 50-day median on 2023-05-17; price +5.5% that day.
FebValuationP/E fell below the 10th percentile of its own history to date (3.4x).
2022
NovPriceVolume reached 9.2x its 50-day median on 2022-11-04; price +6.5% that day.
SepPriceVolume reached 12.7x its 50-day median on 2022-09-05; price +8.2% that day.
JunPeer rankSlipped to the 3rd quartile of Producer Manufacturing on ROCE (from the 2nd quartile).
JunDividendDividend payout cut from 21% to 4% of profit.
MarPeer rankSlipped to the 3rd quartile of Producer Manufacturing on EPS growth (from the 2nd quartile).
FebValuationP/E fell below the 10th percentile of its own history to date (15.6x).
JanPriceVolume reached 7.1x its 50-day median on 2022-01-17; price +4.9% that day.
2021
SepPriceVolume reached 30.9x its 50-day median on 2021-09-03; price +6.4% that day.
JunResultsYear-on-year EPS growth turned positive.
JunDividendDividend payout cut from 45% to 21% of profit.

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Monthly history60 months · 2021-12 to 2026-11

Month	P/E	Revenue (TTM)	ROE	ROCE	Debt / Equity
2026-11	35.2x	₹18829 cr	6.7%	9.0%	0.1x
2026-10	30.6x	₹18829 cr	6.7%	9.0%	0.1x
2026-09	37.7x	₹18829 cr	6.7%	9.0%	0.1x
2026-08	43.8x	₹17996 cr	6.2%	9.0%	0.1x
2026-07	44.8x	₹17996 cr	6.2%	9.0%	0.1x
2026-06	38.6x	₹17996 cr	6.2%	9.0%	0.1x
2026-05	39.8x	₹17596 cr	6.0%	9.0%	0.1x
2026-04	37.1x	₹17596 cr	6.0%	9.0%	0.1x
2026-03	29.6x	₹17596 cr	6.0%	9.0%	0.1x
2026-02	36.1x	₹17412 cr	5.7%	9.0%	0.1x
2026-01	34.7x	₹17412 cr	5.7%	9.0%	0.1x
2025-12	39.1x	₹17412 cr	5.7%	9.0%	0.1x
2025-11	37.6x	₹17497 cr	6.1%	9.0%	0.1x
2025-10	38.3x	₹17497 cr	6.1%	9.0%	0.1x
2025-09	39.2x	₹17497 cr	6.1%	9.0%	0.1x
2025-08	42.4x	₹17238 cr	5.8%	9.0%	0.1x
2025-07	41.1x	₹17238 cr	5.8%	9.0%	0.1x
2025-06	41.5x	₹17238 cr	5.8%	9.0%	0.1x
2025-05	41.5x	₹17076 cr	6.2%	10.0%	0.1x
2025-04	37.7x	₹17076 cr	6.2%	10.0%	0.1x
2025-03	38.7x	₹17076 cr	6.2%	10.0%	0.1x
2025-02	35.3x	₹17039 cr	6.5%	10.0%	0.1x
2025-01	38.1x	₹17039 cr	6.5%	10.0%	0.1x
2024-12	42.3x	₹17039 cr	6.5%	10.0%	0.1x
2024-11	44.0x	₹16961 cr	6.8%	10.0%	0.1x
2024-10	44.3x	₹16961 cr	6.8%	10.0%	0.1x
2024-09	48.8x	₹16961 cr	6.8%	10.0%	0.1x
2024-08	47.8x	₹16770 cr	6.9%	10.0%	0.1x
2024-07	50.7x	₹16770 cr	6.9%	10.0%	0.1x
2024-06	54.7x	₹16770 cr	6.9%	10.0%	0.1x
2024-05	50.4x	₹15078 cr	7.4%	10.0%	0.1x
2024-04	48.8x	₹15078 cr	7.4%	10.0%	0.1x
2024-03	31.5x	₹15078 cr	7.4%	10.0%	0.1x
2024-02	33.1x	₹15078 cr	7.4%	10.0%	0.1x
2024-01	34.6x	₹15078 cr	7.4%	10.0%	0.1x
2023-12	32.8x	₹15078 cr	7.4%	10.0%	0.1x
2023-11	29.4x	₹15078 cr	7.4%	10.0%	0.1x
2023-10	26.4x	₹15078 cr	7.4%	10.0%	0.1x
2023-09	26.9x	₹15078 cr	7.4%	10.0%	0.1x
2023-08	27.6x	₹15078 cr	7.4%	10.0%	0.1x
2023-07	25.8x	₹15078 cr	7.4%	10.0%	0.1x
2023-06	24.5x	₹15078 cr	7.4%	10.0%	0.1x
2023-05	4.1x	₹12789 cr	41.2%	11.0%	0.0x
2023-04	3.8x	₹12789 cr	41.2%	11.0%	0.0x
2023-03	3.5x	₹12789 cr	41.2%	11.0%	0.0x
2023-02	3.4x	₹12789 cr	41.2%	11.0%	0.0x
2023-01	3.5x	₹12789 cr	41.2%	11.0%	0.0x
2022-12	3.5x	₹12789 cr	41.2%	11.0%	0.0x
2022-11	3.7x	₹12789 cr	41.2%	11.0%	0.0x
2022-10	3.2x	₹12789 cr	41.2%	11.0%	0.0x
2022-09	3.1x	₹12789 cr	41.2%	11.0%	0.0x
2022-08	3.1x	₹12789 cr	41.2%	11.0%	0.0x
2022-07	3.1x	₹12789 cr	41.2%	11.0%	0.0x
2022-06	2.7x	₹12789 cr	41.2%	11.0%	0.0x
2022-05	15.4x	₹10359 cr	11.0%	14.0%	0.1x
2022-04	16.1x	₹10359 cr	11.0%	14.0%	0.1x
2022-03	15.9x	₹10359 cr	11.0%	14.0%	0.1x
2022-02	15.6x	₹10359 cr	11.0%	14.0%	0.1x
2022-01	18.2x	₹10359 cr	11.0%	14.0%	0.1x
2021-12	17.7x	₹10359 cr	11.0%	14.0%	0.1x

Older months are in the live observatory.

Methodology and data notes